Institut Sainte Catherine

corporate_fareorganization

Web page: http://www.institut-sainte-catherine.org/

Country: France

ISNI: 0000000406396413

ROR: https://ror.org/04q9mdf26

Institut Sainte Catherine

- Funding / Projects
  (11)

11 Projects, page 1 of 3

Cancer du sein triple négatif : incidence des mutations des gênes BRCA1/2, PALB2, P53, Corrélation aux profils moléculaires et implications pronostiques Breast cancer: incidence of BRCA1/BRCA2 Mutations, correlation to moleculares profils and pronostic implications
assignment_turned_inProjectPartners:Institut Sainte Catherine, Institut Sainte Catherine, NOP, Centre Jean Perrin, Centre Antoine Lacassagne +5 partners
Institut Sainte Catherine,
Institut Sainte Catherine,
NOP,
Centre Jean Perrin,
Centre Antoine Lacassagne,
Institut Paoli-Calmettes- (IPC),
CHU Marseille - Hôpital la Timone,
CHU Marseille - Hôpital la Timone,
Ausl 4 Piazza Ospedale,
NOP
Funder: Institut National du Cancer Project Code: INCa-DGOS-2596
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
ESOSTRATE 01 Randomised phase II-III strategic trial in operable œsophageal cancer in case of clinical complete response after chemoradiation: systematic surgery versus selective salvage surgery in case of operable recurrence
assignment_turned_inProjectPartners:Centre Hospitalier Universitaire de Clermont-Ferrand, Clinique armoricaine de radiologie, Hôpital Nord, Hôpital Claude Huriez, Hôpital le Bocage +27 partners
Centre Hospitalier Universitaire de Clermont-Ferrand,
Clinique armoricaine de radiologie,
Hôpital Nord,
Hôpital Claude Huriez,
Hôpital le Bocage,
Institut Sainte Catherine,
Hôpital Avicenne,
Groupe Hospitalier Pitié Salpétrière,
Hôpital Trousseau,
Hôpital Haut-Lévêque,
Hôpital Robert Debré,
Hôpital Européen Georges Pompidou (HEGP) - AP-HP,
Institut de Cancérologie de l'Ouest,
Institut Claudius Rega,
Hôpital Hautepierre (CHRU),
PBNA,
Centre Hospitalier Universitaire de Rennes,
Institut Sainte Catherine,
Hôpital Saint-Antoine,
Centre Hospitalier Départemental de Vendée - La Roche-sur-Yon,
Centre Antoine Lacassagne,
CHU,
Polyclinique de Pontivy,
PBNA,
Hôpital Tenon,
Hôpital privé Jean Mermoz,
CHU Marseille - Hôpital la Timone,
Institut Mutualiste Montsouris,
CHU Marseille - Hôpital la Timone,
Polyclinique du Bois,
Centre Hospitalier Universitaire de Rennes,
Centre Hospitalier Universitaire de Clermont-Ferrand
Funder: Institut National du Cancer Project Code: INCa-DGOS-7221
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
A phase III multi centre double-blind placebo controlled study analysing the efficacy and safety of daily administration of a P2Y12 inhibitor (clopidogrel) for the treatment of pancreatic cancer
assignment_turned_inProjectPartners:Institut Gustave Roussy, Hôpital Saint Eloi, Hôpital de l'Archet, Association de Radiothérapie et de Chimiothérapie Oncologique du Val-de-Grâce (ARCOVAL), Institut Sainte Catherine +8 partners
Institut Gustave Roussy,
Hôpital Saint Eloi,
Hôpital de l'Archet,
Association de Radiothérapie et de Chimiothérapie Oncologique du Val-de-Grâce (ARCOVAL),
Institut Sainte Catherine,
Institut Sainte Catherine,
Hôpital Beaujon,
Institut Paoli-Calmettes- (IPC),
Hôpital privé Jean Mermoz,
Hôpital Saint-Louis,
Hôpital Nord,
Hôpital Saint-Louis,
Hôpital de Rangueil
Funder: Institut National du Cancer Project Code: INCa-DGOS-7310
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
STEREO-POSTOP-01 A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early stage oropharyngeal and oral cavity cancers with high risk margins.
assignment_turned_inProjectPartners:Institut Gustave Roussy, Centre Léon Bérard, Centre Antoine Lacassagne, Centre Jean Perrin, Centre Paul Strauss +8 partners
Institut Gustave Roussy,
Centre Léon Bérard,
Centre Antoine Lacassagne,
Centre Jean Perrin,
Centre Paul Strauss,
Institut Sainte Catherine,
Institut de Cancérologie de Lorraine,
Centre Léon Bérard,
Hôpital Européen Georges Pompidou (HEGP) - AP-HP,
Institut Sainte Catherine,
Centre Eugène Marquis,
Hôpital Bretonneau,
Institut Claudius Regaud
Funder: Institut National du Cancer Project Code: INCa-DGOS-11156
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Centre d’essais cliniques de phase précoce de l’Institut Paoli-Calmettes (IPC)
assignment_turned_inProject2011 - 2015Partners:Hôpital d'Instruction des Armées Sainte-Anne, Institut Curie, Centre Hospitalier Avignon Henri Duffaut, Centre Hospitalier Intercommunal Toulon-La Seyne-sur-Mer, Institut Paoli-Calmettes- (IPC) +6 partners
Hôpital d'Instruction des Armées Sainte-Anne,
Institut Curie,
Centre Hospitalier Avignon Henri Duffaut,
Centre Hospitalier Intercommunal Toulon-La Seyne-sur-Mer,
Institut Paoli-Calmettes- (IPC),
Hôpital d'Instruction des Armées Sainte-Anne,
Institut Sainte Catherine,
Centre Hospitalier du Pays d'Aix,
Institut Sainte Catherine,
Centre Hospitalier du Pays d'Aix,
Centre Hospitalier Avignon Henri Duffaut
Funder: Institut National du Cancer Project Code: INCa-3485
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
3
chevron_right

Institut Sainte Catherine

Institut Sainte Catherine

11 Projects, page 1 of 3

Cancer du sein triple négatif : incidence des mutations des gênes BRCA1/2, PALB2, P53, Corrélation aux profils moléculaires et implications pronostiques Breast cancer: incidence of BRCA1/BRCA2 Mutations, correlation to moleculares profils and pronostic implications

ESOSTRATE 01 Randomised phase II-III strategic trial in operable œsophageal cancer in case of clinical complete response after chemoradiation: systematic surgery versus selective salvage surgery in case of operable recurrence

A phase III multi centre double-blind placebo controlled study analysing the efficacy and safety of daily administration of a P2Y12 inhibitor (clopidogrel) for the treatment of pancreatic cancer

STEREO-POSTOP-01 A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early stage oropharyngeal and oral cavity cancers with high risk margins.

Centre d’essais cliniques de phase précoce de l’Institut Paoli-Calmettes (IPC)

Loading